Ranbaxy elevates Atul Sobti as COO

NEW DELHI: Ranbaxy Laboratories on Monday announced the appointment of Atul Sobti as the company’s chief operating officer with effect from January 1, 2007. Mr Sobti will be responsible for global business operations, manufacturing and generic development.

He will continue to report to Malvinder Singh, CEO and MD, Ranbaxy. Mr Sobti is currently president, Asia, global consumer healthcare and API global business unit.

Announcing Mr Sobti’s elevation as the chief operating officer, Mr Singh said, “With continued aggressive growth plans in 2007 and beyond, we need to ensure an integrated, cohesive and cost effective organisation globally, with greater interaction and seamless interface amongst all facets of the value adding process from the lab to market.”

The Ranbaxy chief executive said the COO’s position will effectively bring about these improved efficiencies by integrating leadership and accountability for the global P&L.